BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 36726115)

  • 21. Differential gene expression of tumor-infiltrating CD8
    Saleh R; Sasidharan Nair V; Toor SM; Taha RZ; Murshed K; Al-Dhaheri M; Khawar M; Petkar MA; Abu Nada M; Al-Ejeh F; Elkord E
    J Immunother Cancer; 2020 Sep; 8(2):. PubMed ID: 32948653
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Prognostic Significance of the Tumor-infiltrating Programmed Cell Death-1
    Shibutani M; Maeda K; Nagahara H; Fukuoka T; Nakao S; Matsutani S; Hirakawa K; Ohira M
    Anticancer Res; 2017 Aug; 37(8):4165-4172. PubMed ID: 28739701
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic value of tumor-infiltrating lymphocytes in triple-negative breast cancers from two phase III randomized adjuvant breast cancer trials: ECOG 2197 and ECOG 1199.
    Adams S; Gray RJ; Demaria S; Goldstein L; Perez EA; Shulman LN; Martino S; Wang M; Jones VE; Saphner TJ; Wolff AC; Wood WC; Davidson NE; Sledge GW; Sparano JA; Badve SS
    J Clin Oncol; 2014 Sep; 32(27):2959-66. PubMed ID: 25071121
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Density and location of CD3
    Zhou C; Wu Y; Jiang L; Li Z; Diao P; Wang D; Zhang W; Liu L; Wang Y; Jiang H; Cheng J; Yang J
    J Oral Pathol Med; 2018 Apr; 47(4):359-367. PubMed ID: 29469989
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic impact of immune microenvironment in laryngeal and pharyngeal squamous cell carcinoma: Immune cell subtypes, immuno-suppressive pathways and clinicopathologic characteristics.
    Karpathiou G; Casteillo F; Giroult JB; Forest F; Fournel P; Monaya A; Froudarakis M; Dumollard JM; Prades JM; Peoc'h M
    Oncotarget; 2017 Mar; 8(12):19310-19322. PubMed ID: 28038471
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Morphological Evaluation of Tumor-Infiltrating Lymphocytes (TILs) to Investigate Invasive Breast Cancer Immunogenicity, Reveal Lymphocytic Networks and Help Relapse Prediction: A Retrospective Study.
    Romagnoli G; Wiedermann M; Hübner F; Wenners A; Mathiak M; Röcken C; Maass N; Klapper W; Alkatout I
    Int J Mol Sci; 2017 Sep; 18(9):. PubMed ID: 28885584
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differential Immune Infiltration Profiles in Colitis-Associated Colorectal Cancer versus Sporadic Colorectal Cancer.
    Schardey J; Lu C; Neumann J; Wirth U; Li Q; Jiang T; Zimmermann P; Andrassy J; Bazhin AV; Werner J; Kühn F
    Cancers (Basel); 2023 Sep; 15(19):. PubMed ID: 37835436
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization and spatial distribution of the immune cell infiltrate in triple-negative breast cancer: a novel classification based on plasma cells and CD8+ T cells.
    Gonzàlez-Farré M; Gibert J; Santiago-Díaz P; Menéndez S; Monzonis X; Olivares F; Riera X; López D; Torner A; Casado B; Bellosillo B; Lloveras B; Casadevall D; Rovira A; Servitja S; Albanell J; Vázquez I; Comerma L
    Hum Pathol; 2023 Sep; 139():91-105. PubMed ID: 37517596
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The prognostic value of tumor-infiltrating lymphocytes in colorectal cancer differs by anatomical subsite: a systematic review and meta-analysis.
    Zhao Y; Ge X; He J; Cheng Y; Wang Z; Wang J; Sun L
    World J Surg Oncol; 2019 May; 17(1):85. PubMed ID: 31118034
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comprehensive Molecular Profiling of Colorectal Cancer With Situs Inversus Totalis by Next-Generation Sequencing.
    Li H; Gong L; Cheng H; Wang H; Zhang X; Rao C; Song Z; Wang D; Lou H; Lou F; Cao S; Pan H; Fang Y
    Front Oncol; 2022; 12():813253. PubMed ID: 35530355
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic value of tumor-infiltrating B lymphocytes and plasma cells in triple-negative breast cancer.
    Kuroda H; Jamiyan T; Yamaguchi R; Kakumoto A; Abe A; Harada O; Enkhbat B; Masunaga A
    Breast Cancer; 2021 Jul; 28(4):904-914. PubMed ID: 33629216
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinicopathological significance and prognostic role of LAG3 + tumor-infiltrating lymphocytes in colorectal cancer; relationship with sidedness.
    Tavana S; Mokhtari Z; Sanei MH; Heidari Z; Dehghanian AR; Faghih Z; Rezaei M
    Cancer Cell Int; 2023 Feb; 23(1):23. PubMed ID: 36765348
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tumour infiltrating lymphocytes and apoptosis are independent features in colorectal cancer stratified according to microsatellite instability status.
    Michael-Robinson JM; Biemer-Hüttmann A; Purdie DM; Walsh MD; Simms LA; Biden KG; Young JP; Leggett BA; Jass JR; Radford-Smith GL
    Gut; 2001 Mar; 48(3):360-6. PubMed ID: 11171826
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tumor-infiltrating lymphocyte: features and prognosis of lymphocytes infiltration on colorectal cancer.
    Qin M; Chen G; Hou J; Wang L; Wang Q; Wang L; Jiang D; Hu Y; Xie B; Chen J; Wei H; Xu G
    Bioengineered; 2022 Jun; 13(6):14872-14888. PubMed ID: 36633318
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tumor infiltrating lymphocytes: an intriguing player in the survival of colorectal cancer patients.
    Deschoolmeester V; Baay M; Van Marck E; Weyler J; Vermeulen P; Lardon F; Vermorken JB
    BMC Immunol; 2010 Apr; 11():19. PubMed ID: 20385003
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Residual cancer burden index and tumor-infiltrating lymphocyte subtypes in triple-negative breast cancer after neoadjuvant chemotherapy.
    Pinard C; Debled M; Ben Rejeb H; Velasco V; Tunon de Lara C; Hoppe S; Richard E; Brouste V; Bonnefoi H; MacGrogan G
    Breast Cancer Res Treat; 2020 Jan; 179(1):11-23. PubMed ID: 31529299
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The CD4/CD8 ratio of tumor-infiltrating lymphocytes at the tumor-host interface has prognostic value in triple-negative breast cancer.
    Wang K; Shen T; Siegal GP; Wei S
    Hum Pathol; 2017 Nov; 69():110-117. PubMed ID: 28993275
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tumor-associated CD3- and CD8-positive immune cells in colorectal cancer: The additional prognostic value of CD8+-to-CD3+ ratio remains debatable.
    Kasurinen J; Hagström J; Kaprio T; Beilmann-Lehtonen I; Haglund C; Böckelman C
    Tumour Biol; 2022; 44(1):37-52. PubMed ID: 35404299
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High tissue expression of TLRs combined with high density of tumor infiltrating lymphocytes predicts a better prognosis in colorectal cancer patients.
    Beilmann-Lehtonen I; Kasurinen J; Hagström J; Kaprio T; Böckelman C; Haglund C
    PLoS One; 2023; 18(1):e0280085. PubMed ID: 36649244
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tumor microenvironment in triple-negative breast cancer: the correlation of tumor-associated macrophages and tumor-infiltrating lymphocytes.
    Kuroda H; Jamiyan T; Yamaguchi R; Kakumoto A; Abe A; Harada O; Masunaga A
    Clin Transl Oncol; 2021 Dec; 23(12):2513-2525. PubMed ID: 34089486
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.